Biolinq is a startup based in the United States, most recent round Series-c-plus, 2 tracked investors.
Based in the United States, Biolinq is a startup founded in 2012. Its most recent tracked round is Series-c-plus. Brouky records 2 investors associated with the company.
Biolinq develops a wearable biosensor platform that measures glucose levels and integrates activity and sleep data, providing real-time feedback through a color-changing indicator light to help manage metabolic health.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.